BioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetsTwo of the largest ever biotech IPOs have gone ahead this week, although both BioNTech and Vir Biotechnology Share XBioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetshttps://pharmaphorum.com/news/biontech-and-virs-mega-ipos-go-ahead-but-struggle-to-meet-price-targets/
BioNTech and Vir prepare mega-IPOs after flurry of launchesTwo of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, Share XBioNTech and Vir prepare mega-IPOs after flurry of launcheshttps://pharmaphorum.com/news/biontech-and-vir-prepare-mega-ipos-after-flurry-of-launches/
Pfizer invests in mRNA vaccine powerhouse BioNTechPfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of Share XPfizer invests in mRNA vaccine powerhouse BioNTechhttps://pharmaphorum.com/news/pfizer-invests-mrna-vaccine-biontech/
